ALKERMES | 销售和管理费用

金融业

USD

USD 2.33B

现金及等价物

USD 616.45M

USD 51.59M

USD 1.74B

USD 474.36M

USD 71.6M

股息收益率

0

USD 89.08M

USD 121.55M

1.8K

EPS每股收益

USD 0.49

股本和储备

USD 1.73B

USD 265.83M

债务利息支出

USD 4.65M

USD 11.94M

USD 285.82M

USD 5.16B

USD 82.76M

USD 1.73B

USD 89.08M

普通股股本

USD 165.1M

USD 14.9

USD 100.74M

USD 394.2M

销售和管理费用

USD 171.77M

USD 191M

贸易债权人

USD 68M

应收帐款人

USD 355.11M

	销售和管理费用	更改		日
AbbVie	USD 3.89B		325M	2025-12
Acadia Pharmaceuticals	USD 124.9M		1.24M	2025-09
ALKERMES	USD 171.77M		17.9M	2025-09
Amgen	USD 1.94B		237M	2025-12
Biogen	USD 545.2M		38.6M	2025-09
BioMarin Pharmaceutical	USD 322.21M		98.79M	2025-12
Bristol-Myers Squibb	USD 2.18B		392M	2025-12
Coherus Biosciences	USD 26.02M		8.57M	2025-03
Eli Lilly	USD 3.13B		391.3M	2025-12
Gilead Sciences	USD 1.78B		425M	2025-12
Heron Therapeutics	USD 23.34M		4.18M	2024-09
Ionis Pharmaceuticals	USD 86.56M		4.04M	2025-09
J&J	USD 6.75B		831M	2025-12
Malin Corporation	EUR 1.1M		400K	2024-12
Merck	USD 2.85B		215M	2025-12
Minerva Neurosciences	USD 2.48M		58.79K	2024-09
Nektar Therapeutics	USD -0.18		0.07	2024-09
Neurocrine Biosciences	USD 301.8M		10.2M	2025-12
Otsuka Holdings	JPY 278.3B		24.08B	2025-12
Ovoca Bio	EUR 2.96M		8K	2022-06
Pfizer	USD 4.08B		894M	2025-12
Regeneron Pharmaceuticals	USD 775M		117.2M	2025-12
Vertex Pharmaceuticals	USD 487M		41.9M	2025-12

ALKERMES 销售和管理费用 - 当前值，历史数据，预测，统计，图表和经济日历 - Feb 2026.